0001209191-17-029346.txt : 20170502
0001209191-17-029346.hdr.sgml : 20170502
20170502180107
ACCESSION NUMBER: 0001209191-17-029346
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170501
FILED AS OF DATE: 20170502
DATE AS OF CHANGE: 20170502
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: INCYTE CORP
CENTRAL INDEX KEY: 0000879169
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
IRS NUMBER: 943136539
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1801 AUGUSTINE CUT-OFF
CITY: WILMINGTON
STATE: DE
ZIP: 19803
BUSINESS PHONE: 3024986700
MAIL ADDRESS:
STREET 1: 1801 AUGUSTINE CUT-OFF
CITY: WILMINGTON
STATE: DE
ZIP: 19803
FORMER COMPANY:
FORMER CONFORMED NAME: INCYTE CORP
DATE OF NAME CHANGE: 20030318
FORMER COMPANY:
FORMER CONFORMED NAME: INCYTE GENOMICS INC
DATE OF NAME CHANGE: 20000710
FORMER COMPANY:
FORMER CONFORMED NAME: INCYTE PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19930902
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Flannelly Barry P
CENTRAL INDEX KEY: 0001615842
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-12400
FILM NUMBER: 17806520
MAIL ADDRESS:
STREET 1: ROUTE 141 AND HENRY CLAY ROAD
CITY: WILMINGTON
STATE: DE
ZIP: 19880
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-05-01
0
0000879169
INCYTE CORP
INCY
0001615842
Flannelly Barry P
1801 AUGUSTINE CUT-OFF
WILMINGTON
DE
19803
0
1
0
0
EVP & General Manager US
Common Stock
2017-05-01
4
M
0
2064
48.44
A
17949
D
Common Stock
2017-05-01
4
S
0
803
124.61
D
17146
D
Common Stock
2017-05-01
4
S
0
4493
124.75
D
12653
D
Incentive Stock Option (right to buy)
48.44
2017-05-01
4
M
0
2064
0.00
D
2021-08-10
Common Stock
2064
1720
D
Reporting person undertakes to provide upon request by Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within range indicated.
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person.
Represents weighted average sale price. Actual sale prices ranged from $123.97 - $125.38.
Represents weighted average sale price. Actual sale prices ranged from $123.92 - $125.47.
Includes an aggregate of 11,187 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.
Beginning August 11, 2014, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years
/s/ Barry Flannelly
2017-05-02